These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8510139)

  • 1. The effects of RU 41.740, a glycoprotein immunomodulating agent derived from Klebsiella pneumoniae, on intra-abdominal abscess formation in mice.
    Finlay-Jones JJ; Boyden AN; Tillett EJ; Hart PH; Spencer LK; Reznikov M; McDonald PJ
    J Med Microbiol; 1993 Jun; 38(6):454-8. PubMed ID: 8510139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-abdominal abscess formation in mice: quantitative studies on bacteria and abscess-potentiating agents.
    Nulsen MF; Finlay-Jones JJ; Skinner JM; McDonald PJ
    Br J Exp Pathol; 1983 Aug; 64(4):345-53. PubMed ID: 6311236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of macrophage procoagulant activity with lipids reduces intra-abdominal abscess formation in mice.
    Sawyer RG; Pruett TL
    Eur Surg Res; 1995; 27(4):222-6. PubMed ID: 7649208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of intra-abdominal abscesses with fibrinolytic agents.
    Rosenthal GA; Quinto J; Kao J; Rotstein OD
    Can J Surg; 1988 Mar; 31(2):98-100. PubMed ID: 3127033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial killing in vitro by abscess-derived neutrophils.
    Finlay-Jones JJ; Hart PH; Spencer LK; Nulsen MF; Kenny PA; McDonald PJ
    J Med Microbiol; 1991 Feb; 34(2):73-81. PubMed ID: 1990143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of intraabdominal abscess formation: abscess-potentiating agents and inhibition of complement-dependent opsonization of abscess-inducing bacteria.
    Finlay-Jones JJ; Kenny PA; Nulsen MF; Spencer LK; Hill NL; McDonald PJ
    J Infect Dis; 1991 Dec; 164(6):1173-9. PubMed ID: 1659600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of RU 41.740, a glycoprotein extract from Klebsiella pneumoniae, on the murine system. II. RU 41.740 facilitates the response to Con A in otherwise unresponsive T-enriched cells.
    Wood CD; Möller G
    J Immunol; 1985 Jul; 135(1):131-6. PubMed ID: 3889153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auto-cross-linked hyaluronic acid gel does not reduce intra-abdominal adhesions or abscess formation in a rat model of peritonitis.
    Sikkink CJ; de Man B; Bleichrodt RP; van Goor H
    J Surg Res; 2006 Dec; 136(2):255-9. PubMed ID: 17059836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of murine B lymphocytes by RU 41740, a glycoprotein extract from Klebsiella pneumoniae].
    Guenounou M; Smets P; Agneray J
    C R Acad Sci III; 1984; 298(6):135-8. PubMed ID: 6424899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Escherichia coli haemolysin in the pathogenic synergy of colonic bacteria in subcutaneous abscess formation in mice.
    Ushijima T; Takahashi M; Seto A
    J Med Microbiol; 1990 Sep; 33(1):17-22. PubMed ID: 2146395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of an immunomodulator, RU 41740, on experimental infections].
    Joly V
    Presse Med; 1988 Jul; 17(28):1430-2. PubMed ID: 2971180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of muramyl dipeptide and clindamycin in a murine abdominal abscess model.
    Cheadle WG; Brown GL; Lamont PM; Trachtenberg LS; Polk HC
    J Surg Res; 1986 Sep; 41(3):319-25. PubMed ID: 3762139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
    Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
    Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced resistance of mice against influenza virus infection after local administration of glycoprotein extracts from Klebsiella pneumoniae.
    Rudent A; Zalisz R; Quero AM; Smets P
    Int J Immunopharmacol; 1985; 7(4):525-31. PubMed ID: 2412973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of RU 41.740, a glycoprotein extract from Klebsiella pneumoniae, on the murine immune system. I. T-independent polyclonal B cell activation.
    Wood CD; Möller G
    J Immunol; 1984 Feb; 132(2):616-21. PubMed ID: 6197468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial synergy in experimental intra-abdominal abscess.
    Onderdonk AB; Bartlett JG; Louie T; Sullivan-Seigler N; Gorbach SL
    Infect Immun; 1976 Jan; 13(1):22-6. PubMed ID: 814099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of murine intra-abdominal abscess formation.
    Cheadle WG; Hershman MJ; Pietsch JD; Logan WA; Polk HC
    Arch Surg; 1988 Nov; 123(11):1342-6. PubMed ID: 3178482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of human blood monocyte microbicidal activity by RU 41740, a glycoprotein extract from Klebsiella pneumoniae.
    Nielsen H
    Eur J Clin Pharmacol; 1986; 30(1):99-104. PubMed ID: 3011439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.